Back to news

Why The Clorox Company (CLX) Stock Is Up Today

Investivoq PriceTracker

The Clorox Company (CLX) is up 3.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued momentum from Clorox’s better-than-expected fiscal first-quarter results and its decision to keep full-year sales and adjusted EPS guidance in place. A recent open-market purchase by a board member may also be reinforcing investor confidence. This could also be because money has been rotating toward more defensive consumer staples names.

Details:

  • Clorox reported fiscal Q1 2027 adjusted EPS of $1.55, up sharply from the prior-year quarter, while net sales rose 33% and organic sales increased 18%.
  • Management said first-quarter performance was better than expected, helped by strong execution and timing benefits, even though input-cost inflation remained a headwind.
  • The company maintained its fiscal 2027 outlook for net sales growth of 13% to 14% and adjusted EPS of $5.70 to $6.00, though it now expects results near the low end because of higher costs.
  • An SEC Form 4 filed on November 5 showed director Pierre Breber bought 4,000 shares at about $100.06 each on November 4, a roughly $400,000 open-market purchase.
  • Sources:

    The Clorox Company, SEC, AP News

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $CLX Insider Trading Activity

    CLX Insider Trades

    $CLX insiders have traded $CLX stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $CLX stock by insiders over the last 6 months:

    • PIERRE R BREBER purchased 4,000 shares for an estimated $400,250

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    Investivoq Alerts
    Receive CLX Data Alerts
    Get market-moving data, filings, and signals for CLX in real time.
    Sign Up

    $CLX Hedge Fund Activity

    We have seen 490 institutional investors add shares of $CLX stock to their portfolio, and 598 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • BEUTEL, GOODMAN & CO LTD. added 2,012,569 shares (+inf%) to their portfolio in Q3 2026, for an estimated $163,038,214
    • POINT72 ASSET MANAGEMENT, L.P. removed 1,592,288 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $151,967,966
    • MILLENNIUM MANAGEMENT LLC added 1,381,163 shares (+199.6%) to their portfolio in Q2 2026, for an estimated $131,818,196
    • INVESCO LTD. added 1,150,832 shares (+23.7%) to their portfolio in Q2 2026, for an estimated $109,835,406
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,137,006 shares (+inf%) to their portfolio in Q2 2026, for an estimated $108,515,852
    • UBS GROUP AG added 1,066,071 shares (+116.6%) to their portfolio in Q2 2026, for an estimated $101,745,816
    • WORLDQUANT MILLENNIUM ADVISORS LLC added 820,913 shares (+inf%) to their portfolio in Q2 2026, for an estimated $78,347,936

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $CLX Congressional Stock Trading

    Members of Congress have traded $CLX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

    Here’s a breakdown of recent trading of $CLX stock by members of Congress over the last 6 months:

    • REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/15.

    To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.